What does PHARMACIE LEJEUNE VDM do?

PHARMACIE LEJEUNE VDM is a pharmacy in Lierneux. Public Limited, started on 13 March 1998, 1 establishment.

What is the address of PHARMACIE LEJEUNE VDM?

The registered office of PHARMACIE LEJEUNE VDM is located at Rue du Doyard 12, 4990 Lierneux.

Is PHARMACIE LEJEUNE VDM still active?

Yes. According to the CBE (29 October 2026) PHARMACIE LEJEUNE VDM is active, legal situation “Normale toestand”, started on 13 March 1998.

Is PHARMACIE LEJEUNE VDM registered on Peppol?

Yes, PHARMACIE LEJEUNE VDM is registered on the Peppol network with ID 0208:0462876674.

What is the enterprise number of PHARMACIE LEJEUNE VDM?

The enterprise number of PHARMACIE LEJEUNE VDM is BE0462876674.

When was PHARMACIE LEJEUNE VDM founded?

PHARMACIE LEJEUNE VDM was founded on 13 March 1998.

Who are the directors of PHARMACIE LEJEUNE VDM?

According to the 2025 annual accounts, the directors of PHARMACIE LEJEUNE VDM are: SANDRA MARLY, FREDERIC LEJEUNE, CLAUDE LEJEUNE.

Is PHARMACIE LEJEUNE VDM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 March 1998; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did PHARMACIE LEJEUNE VDM make in 2025?

PHARMACIE LEJEUNE VDM posted a profit after taxes of € 3,732 in financial year 2025.

What is the revenue of PHARMACIE LEJEUNE VDM?

As a small company, PHARMACIE LEJEUNE VDM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 158,930.

How much does an employee at PHARMACIE LEJEUNE VDM earn?

The average wage cost per full-time employee at PHARMACIE LEJEUNE VDM was € 45,300 in 2025: staff costs of € 131,509 for 2.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE LEJEUNE VDM have?

According to the 2025 annual accounts, PHARMACIE LEJEUNE VDM has 2.9 full-time equivalents (FTE).

PHARMACIE LEJEUNE VDM (Public Limited) - Lierneux

Dossier PHARMACIE LEJEUNE VDM, printed on 29 October 2026 from databakkes.be/en/0462876674/pharmacie-lejeune-vdm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE LEJEUNE VDM from Lierneux, company number BE0462876674, closed financial year 2025 with a result of € 3,732 after tax. For that financial year PHARMACIE LEJEUNE VDM recorded a gross margin of € 158,930 and equity of € 672,326. Compared with financial year 2024, the result moved from € 5,612 to € 3,732. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Growing

€ 672,326

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 3,732

▼ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 274,437

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 610,353.

People and assets in 2025

Full-time equivalents

2.9

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 131,509

▲ 8% vs 2024

€ 45,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 44,151

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 17,777

▼ 34% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 215,019 Gross margin 2022: € 215,019 First fiscal year in the series	€ 169,088 Gross margin 2023: € 169,088 ▼ 21% vs 2022 (€ 215,019) Unfavourable step	€ 157,192 Gross margin 2024: € 157,192 ▼ 7% vs 2023 (€ 169,088) Unfavourable step	€ 158,930 Gross margin 2025: € 158,930 ▲ 1% vs 2024 (€ 157,192) Favourable step	▲ 1%
Profit after taxes	€ 77,422 Profit after taxes 2022: € 77,422 First fiscal year in the series	€ 28,757 Profit after taxes 2023: € 28,757 ▼ 63% vs 2022 (€ 77,422) Unfavourable step	€ 5,612 Profit after taxes 2024: € 5,612 ▼ 80% vs 2023 (€ 28,757) Unfavourable step	€ 3,732 Profit after taxes 2025: € 3,732 ▼ 33% vs 2024 (€ 5,612) Unfavourable step	▼ 33%
Equity	€ 634,225 Equity 2022: € 634,225 First fiscal year in the series	€ 662,982 Equity 2023: € 662,982 ▲ 5% vs 2022 (€ 634,225) Favourable step	€ 668,594 Equity 2024: € 668,594 ▲ 1% vs 2023 (€ 662,982) Favourable step	€ 672,326 Equity 2025: € 672,326 ▲ 1% vs 2024 (€ 668,594) Favourable step	▲ 1%
Total debts	€ 69,486 Total debts 2022: € 69,486 First fiscal year in the series	€ 89,334 Total debts 2023: € 89,334 ▲ 29% vs 2022 (€ 69,486) Unfavourable step	€ 79,764 Total debts 2024: € 79,764 ▼ 11% vs 2023 (€ 89,334) Favourable step	€ 65,264 Total debts 2025: € 65,264 ▼ 18% vs 2024 (€ 79,764) Favourable step	▼ 18%
Cash	€ 220,479 Cash 2022: € 220,479 First fiscal year in the series	€ 183,603 Cash 2023: € 183,603 ▼ 17% vs 2022 (€ 220,479) Unfavourable step	€ 297,502 Cash 2024: € 297,502 ▲ 62% vs 2023 (€ 183,603) Favourable step	€ 274,437 Cash 2025: € 274,437 ▼ 8% vs 2024 (€ 297,502) Unfavourable step	▼ 8%
Retained profit	€ 572,252 Retained profit 2022: € 572,252 First fiscal year in the series	€ 601,009 Retained profit 2023: € 601,009 ▲ 5% vs 2022 (€ 572,252) Favourable step	€ 606,621 Retained profit 2024: € 606,621 ▲ 1% vs 2023 (€ 601,009) Favourable step	€ 610,353 Retained profit 2025: € 610,353 ▲ 1% vs 2024 (€ 606,621) Favourable step	▲ 1%
Balance sheet total	€ 703,711 Balance sheet total 2022: € 703,711 First fiscal year in the series	€ 752,316 Balance sheet total 2023: € 752,316 ▲ 7% vs 2022 (€ 703,711) Unchanged	€ 748,358 Balance sheet total 2024: € 748,358 ▼ 1% vs 2023 (€ 752,316) Unchanged	€ 737,590 Balance sheet total 2025: € 737,590 ▼ 1% vs 2024 (€ 748,358) Unchanged	▼ 1%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	2 Employees (FTE) 2023: 2 ▼ 0.1 vs 2022 (2.1) Unchanged	2.5 Employees (FTE) 2024: 2.5 ▲ 0.5 vs 2023 (2) Unchanged	2.9 Employees (FTE) 2025: 2.9 ▲ 0.4 vs 2024 (2.5) Unchanged	▲ 0.4

Key figures of PHARMACIE LEJEUNE VDM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LEJEUNE VDM?

What happened at PHARMACIE LEJEUNE VDM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 SANDRA MARLY stepped down as director. NBB
2027 FREDERIC LEJEUNE stepped down as director. NBB
2027 CLAUDE LEJEUNE stepped down as director. NBB
Jun 25, 2026 New annual accounts for financial year 2025: profit of € 3,732 (▼ 33% vs 2024). Source: NBB ↗
2021 SANDRA MARLY became a director. NBB
2021 FREDERIC LEJEUNE became a director. NBB
2021 CLAUDE LEJEUNE became a director. NBB
May 7, 1998 New establishment in Lierneux. KBO

In short

From € 77,422 profit in 2022 to € 3,732 profit in 2025.

Paid € 21,723 in corporate taxes since 2022.

Best year ever: 2022, with € 77,422 profit.

On average € 54,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MEDIXA PHARMA

The stake of MEDIXA PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE LEJEUNE VDM

The shares are held by MEDIXA PHARMA.

Directors

According to the 2025 annual accounts

SANDRA MARLY

Director

since 2021 · until 2027

FREDERIC LEJEUNE

Director

Also active at: LDM Aviation Services

since 2021 · until 2027

CLAUDE LEJEUNE

Managing director

Also active at: CLOFRA

since 2021 · until 2027

Shareholders

MEDIXA PHARMA

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Doyard 12

4990 Lierneux

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MEDIXA PHARMA same network

€ 137,313 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.876.674

VAT number

BE 0462.876.674

Registered office

Rue du Doyard 12, 4990 Lierneux

Names & denominations

PHARMACIE LEJEUNE VDM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

13 March 1998

Peppol

Active · Active since 22 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LEJEUNE VDM

Financials

What happened to PHARMACIE LEJEUNE VDM?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions